CAMP4 Therapeutics Corp. (CAMP)
4.60
+0.95
(+26.03%)
USD |
NASDAQ |
Dec 09, 16:00
4.42
-0.18
(-3.91%)
After-Hours: 20:00
CAMP4 Therapeutics Profit Margin (Quarterly): -1.90K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| TransMedics Group, Inc. | 16.91% |
| Neumora Therapeutics, Inc. | -- |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -123.3% |
| Return on Assets | -88.96% |
| Return on Invested Capital | -104.1% |
| Gross Profit Margin (Quarterly) | 47.67% |
| Operating Margin (Quarterly) | -1.65K% |
| Return on Net Operating Assets | -471.3% |